A groundbreaking ceremony took place at Mayo Clinic’s campus in Phoenix, AZ, marking the start of construction on an 80,000 square foot rehabilitation hospital operated by Brooks Rehabilitation. This state-of-the-art, 60-room facility will specialize in providing care for patients recovering from strokes, organ transplants, advanced cancer treatments, and other complex conditions. https://lnkd.in/g34mwq7N #collaboration #healthcare
Mayo Clinic Ventures
Hospitals and Health Care
Rochester, Minnesota 15,157 followers
We bring Mayo Clinic innovations to the marketplace for the benefit of patients, providers and consumers.
About us
Mayo Clinic Ventures is responsible for commercializing Mayo Clinic’s intellectual property. We develop, manage, protect and license technology that saves lives and advances patient care. Who is Mayo Clinic Ventures? Mayo Clinic Ventures is a mission-driven, global leader in research and technology commercialization housed within Mayo Clinic’s Business Development department. Our multidisciplinary team is comprised of professionals in the fields of technology licensing and IP enterprise management, business and technology development, finance, legal, operations, and admin support across our offices in Rochester, Florida and Arizona. What does Mayo Clinic Ventures do? Mayo Clinic Ventures brings together the perspective of patients, physicians and the healthcare market to find better ways to practice medicine, with new mechanisms, new drugs, new healthcare models and new procedures that are less invasive, more cost-effective and leverage the latest in personalized medicine. We are uniquely qualified to facilitate the advancement of health-related technologies to guide patient-centered solutions to complex health issues. Why do business with Mayo Clinic Ventures? Several of the most widely used medical advancements throughout the world have been developed at Mayo Clinic. Mayo Clinic Ventures is not a traditional tech transfer office — distinct in that it not only licenses Mayo Clinic’s intellectual property, but also forms product development collaborations, actively mines Mayo Clinic for ideas, teaches entrepreneurism, starts companies, runs a business accelerator and participates in a multi-million dollar venture and growth fund that supports economic development. While Mayo Clinic Ventures cannot guarantee that all disclosed inventions and discoveries will be patented or commercialized, we commit our resources to ensure that each technology is given appropriate opportunities to realize its potential. We invite you to make medical history with us.
- Website
-
https://businessdevelopment.mayoclinic.org/
External link for Mayo Clinic Ventures
- Industry
- Hospitals and Health Care
- Company size
- 51-200 employees
- Headquarters
- Rochester, Minnesota
- Founded
- 1985
- Specialties
- Invention Disclosure, Tech Transfer, Commercialization, Patent Filing, Intellectual Property, BioPharma, Research Tools, Business Development, Healthcare IT, Radiology, Devices, Cardiology, Orthopedics, and Diagnostics
Updates
-
Researchers have found that bone morphogenic protein 5 (BMP5) may help repair rotator cuff tendons, potentially lowering costs and recovery time. Mayo Clinic is seeking to collaborate with an orthobiologic or biopharmaceutical company to bring this innovation to market. https://lnkd.in/gM8zWCpr #innovation #orthpedics #collaboration
-
A study led by Dan Billadeau, PhD at Mayo Clinic has found indications that a certain protein plays a role in regulating cell resistance and fighting tumors. NKG7 protein has potential to make T cell-based immunotherapy treatments more robust, thereby improving efficacy and increasing positive patient outcomes. https://lnkd.in/giebA7Ny #innovation #oncology #cancer #immunotherapy
-
A know-how agreement has been signed between Mayo Clinic and Northernmost. This collaboration will test Northernmost’s latest perfusion machine and seeks to advance preservation and transport of donor kidneys using hypothermic machine perfusion. https://lnkd.in/gtnJBCMz #innovation #transplantmedicine
-
For the seventh year in a row, Newsweek has ranked Mayo Clinic as the No. 1 hospital in the world based on patient survey results, an international survey of more than 85,000 healthcare professionals, key performance metrics — such as patient safety and quality of care — and implementation of patient-reported outcomes. https://lnkd.in/gwwdSt2c
-
Cardiac ultrasound is evolving with AI. Mayo Clinic's Paul Friedman, MD, and UltraSight CEO Davidi Vortman were guests on the Tomorrow's Cure podcast to discuss how Mayo Clinic and UltraSight are collaborating to improve and expand access to high-quality cardiac imaging and diagnostics. https://lnkd.in/g_YqZ5RE #innovation #collaboration #cardiology #AI
How Next-Gen Ultrasound Improves Cardiac Care | Tomorrow's Cure Season 2 Episode 6
https://www.youtube.com/
-
Utilizing a Rare Disease Omics strategy, Mayo Clinic researchers are making significant strides to improve diagnoses and develop new treatments. https://lnkd.in/g5fkbv2K #innovation #raredisease #healthcare
-
Researchers at Mayo Clinic have published clinical trial results that show potential for a new drug to significantly slow the progression of aortic valve stenosis (AVS). This important finding is the result of a collaborative effort with the National Institutes of Health, the University of Minnesota and Sanofi Pharmaceuticals. https://lnkd.in/ggSFKKwC #innovation #collaboration #cardiology
-
Mayo Clinic’s Department of Business Development is seeking to commercialize a new device designed to treat stress urinary incontinence (SUI) in women. https://lnkd.in/gM8zWCpr #innovation #collaboration
-
-
Stay connected with the latest news in healthcare technology, innovation, events and more with Mayo Clinic's Business Development monthly newsletter. Sign up today to receive the upcoming March edition: https://lnkd.in/g__cq3mC #medtech #innovation #news
-